Short and Long Sleep Durations May Be Associated With CVD
Sleep duration shorter or longer than 7 hours may be associated with increased cardiovascular health risks.
Sleep/Wake
Psychiatric Disorders Uncommon in Aftermath of Coronavirus Infection
For patients with COVID-19 in the intensive care unit, data showed that 65% of patients experienced delirium, 69% agitation, and 21% altered consciousness.
Serum Biomarkers May Predict Fatigue in Patients With Axial Spondyloarthritis
Researchers evaluated the relationship between patient-reported fatigue and serum biomarkers in axial spondyloarthritis.
Digital CBT Improves Insomnia, Anxiety, and Depression in Pregnant Women
Digital CBT involved 6 weekly remote sessions via website or iOS app lasting approximately 20 minutes and comprised sleep restriction, stimulus control, relaxation techniques, cognitive therapy, and sleep hygiene and education.
Poor Sleep Quality Linked to Greater Food Intake, Worse Diet
Poor sleep quality is associated with increased food intake and a lower-quality diet among women.
Light Therapies Feature Low Attrition and Relatively High Acceptance, Despite Research Drawbacks
While carefully timed light exposure may address sleep problems associated with circadian rhythm disturbances, studies that examine light therapies in the context of sleep disorders have been largely lacking in measures of adherence and acceptability of these approaches.
Mental Health Burden During COVID-19: Anxiety, Depression, and Poor Sleep Quality
Prevalence of GAD and depressive symptoms was significantly higher in participants younger than 35 years as compared to those aged 35 years or older.
Clinical Improvement Observed in Narcolepsy Trial Evaluating Once-Nightly Sodium Oxybate Formulation
Positive topline data from the phase 3 REST-ON trial evaluating FT218 (Avadel), an investigational, once-nightly formulation of sodium oxybate, showed that the treatment led to clinically meaningful improvement in patients with narcolepsy.
The Narcolepsy Severity Scale Is Valid, Reliable in Treatment of Narcolepsy
Researchers suggest the Narcolepsy Severity Scale be used more frequently in the clinical settings and future narcolepsy studies.
Daridorexant Improves Sleep, Daytime Performance in Insomnia Study
Idorsia announced positive topline results from a phase 3 study of daridorexant, an investigational dual orexin receptor antagonist, for the treatment of insomnia.
-
Loading...
-
Loading...
Next post in Insomnia Disorder
